Details of CPPsite entry with Sequence MVTVLFRRLRIRRACGPPRVRV |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | MVTVLFRRLRIRRACGPPRVRV |
| CPPsite ID | 2157, 3000, 3009, 1447, |
| PEPTIDE NAME | M918, Pepfect 2, M918, M918 |
| CHIRALITY | L, Modified, L, L |
| LINEAR/CYCLIC | Linear, Linear, Linear, Linear |
| SOURCE | Synthetic, Synthetic, Synthetic, Protein derived |
| CATEGORY | NA, NA, NA, Amphipathic |
| SUB CELLULAR LOCALIZATION | NA, NA, NA, Vesicles |
| N-TERMINAL MODIFICATION | Free, Stearylation, NA, Conjugation with fluorescein |
| C-TERMINAL MODIFICATION | Free, Amidation, Amidation, Amidation |
| CHEMICAL MODIFICATION | NA, NA, NA, NA |
| UPTAKE EFFICIENCY | NA, NA, NA, Higher than Penetratin |
| PROPOSED UPTAKE MECHANISM | Endocytosis, Endocytosis, Endocytosis, Mainly via endocytic process,and in particular macropinocytosis, but independent of glycosaminoglycans on the cell surface |
| INVITRO/INVIVO | In vitro, In vitro, In vitro, In vitro |
| CELL LINE | HT-29-luc cells, HeLa cells, HeLa cells, HeLa, MCF-7, CHO K1, and Hifko cells |
| In VIVO MODEL | NA, NA, NA, NA |
| CARGO | PNA, Nucelic acid (pGL3 plasmid, SCO), Nucleic acid (SCO), Fluorophore (fluorescein) |
| PMID | 25185512, 17622242 |
| PATENT | Unknown, US 2014/0140929 A1, US 2014/0140929 A1, Unknown |
| Tertiary Structure (Technique) | 2157 (PEPstrMOD), 3000 (PEPstrMOD), 3009 (PEPstrMOD), 1447 (PEPstrMOD), |